Marwa Monier Mahmoud Refaie

12PUBLICATIONS
8CO-AUTHORS
Innate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 27, 2024
Sacubitril/valsartan protective effect on induced intestinal ischemia/reperfusion injury via immune modulation of IL6/STAT1 pathway.

Marwa Monier Mahmoud Refaie, Entesar Farghly Amin, Marwa Nadi Hassan

|Jun 19, 2023
Molecular mechanisms mediate roflumilast protective effect against isoprenaline-induced myocardial injury.

Marwa Monier Mahmoud Refaie, Manar Fouli Gaber Ibrahim, Michael Atef Fawzy

|Jun 01, 2023
Sacubitril/valsartan cardioprotective effect against cisplatin-induced cardiotoxicity via modulation of VEGF/eNOS and TLR4/TNFα/IL6 signalling pathways.

Marwa Monier Mahmoud Refaie, Rehab Ahmed Rifaai, Asmaa M A Bayoumi

|Mar 01, 2023
Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways.

Marwa M M Refaie, Rehab Ahmed Rifaai, Michael Atef Fawzy

|Oct 15, 2022
Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways.

Marwa M M Refaie, Rehab Ahmed Rifaai, Michael Atef Fawzy

Pageof 2